David Shapiro Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David Shapiro.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Shapiro. David Shapiro is CMO & EVP - Development in INTERCEPT PHARMACEUTICALS INC ($ICPT) and CMO and EVP - Development in INTERCEPT PHARMACEUTICALS INC ($ICPT).
Latest Insider Trading Transactions of David Shapiro
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO & EVP - Develop ... | Option Exercise | M | 10.40 | 3,750 | 39,000 | 52,788 | |
| Dec 17 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO & EVP - Develop ... | Sell | S | 62.11 | 5,016 | 311,550 | 3,000 | 8 K to 3 K (-62.57 %) |
| Dec 17 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO & EVP - Develop ... | Buy | M | 10.40 | 3,750 | 39,000 | 8,016 | 4.3 K to 8 K (+87.90 %) |
| Nov 19 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO & EVP - Develop ... | Option Exercise | M | 10.40 | 3,750 | 39,000 | 56,538 | |
| Nov 19 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO & EVP - Develop ... | Sell | S | 48.08 | 4,730 | 227,412 | 4,266 | 9 K to 4.3 K (-52.58 %) |
| Nov 19 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO & EVP - Develop ... | Buy | M | 10.40 | 3,750 | 39,000 | 8,996 | 5.2 K to 9 K (+71.48 %) |
| Oct 03 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO & EVP - Develop ... | Option Exercise | M | 10.40 | 3,750 | 39,000 | 60,288 | |
| Oct 03 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO & EVP - Develop ... | Option Exercise | M | 0.00 | 1,622 | 0 | 14,603 | |
| Oct 03 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO & EVP - Develop ... | Sell | S | 73.10 | 642 | 46,930 | 5,246 | 5.9 K to 5.2 K (-10.90 %) |
| Oct 03 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO & EVP - Develop ... | Sell | S | 74.60 | 600 | 44,760 | 5,888 | 6.5 K to 5.9 K (-9.25 %) |
| Oct 03 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO & EVP - Develop ... | Sell | S | 73.02 | 1,177 | 85,943 | 6,488 | 7.7 K to 6.5 K (-15.36 %) |
| Oct 03 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO & EVP - Develop ... | Sell | S | 72.02 | 1,973 | 142,087 | 7,665 | 9.6 K to 7.7 K (-20.47 %) |
| Oct 03 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO & EVP - Develop ... | Buy | M | 10.40 | 3,750 | 39,000 | 9,638 | 5.9 K to 9.6 K (+63.69 %) |
| Oct 03 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO & EVP - Develop ... | Buy | M | 0.00 | 1,622 | 0 | 5,888 | 4.3 K to 5.9 K (+38.02 %) |
| Sep 18 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO & EVP - Develop ... | Option Exercise | M | 10.40 | 3,750 | 39,000 | 64,038 | |
| Sep 18 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO & EVP - Develop ... | Sell | S | 49.20 | 5,016 | 246,784 | 4,266 | 9.3 K to 4.3 K (-54.04 %) |
| Sep 18 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO & EVP - Develop ... | Buy | M | 10.40 | 3,750 | 39,000 | 9,282 | 5.5 K to 9.3 K (+67.79 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 496 | 5,158 | 79,038 | |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 3,254 | 33,842 | 79,534 | |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.30 | 100 | 3,130 | 3,798 | 3.9 K to 3.8 K (-2.57 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.26 | 100 | 3,126 | 3,898 | 4 K to 3.9 K (-2.50 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.22 | 662 | 20,668 | 3,998 | 4.7 K to 4 K (-14.21 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.22 | 435 | 13,581 | 4,660 | 5.1 K to 4.7 K (-8.54 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.20 | 465 | 14,508 | 5,095 | 5.6 K to 5.1 K (-8.36 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 496 | 5,158 | 5,560 | 5.1 K to 5.6 K (+9.79 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.74 | 100 | 3,174 | 5,064 | 5.2 K to 5.1 K (-1.94 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.70 | 300 | 9,509 | 5,164 | 5.5 K to 5.2 K (-5.49 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.58 | 100 | 3,158 | 5,464 | 5.6 K to 5.5 K (-1.80 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.56 | 100 | 3,156 | 5,564 | 5.7 K to 5.6 K (-1.77 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.54 | 200 | 6,308 | 5,664 | 5.9 K to 5.7 K (-3.41 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.50 | 80 | 2,520 | 5,864 | 5.9 K to 5.9 K (-1.35 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.46 | 10 | 315 | 5,944 | 6 K to 5.9 K (-0.17 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.40 | 100 | 3,140 | 5,954 | 6.1 K to 6 K (-1.65 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.39 | 100 | 3,139 | 6,054 | 6.2 K to 6.1 K (-1.62 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.37 | 100 | 3,137 | 6,154 | 6.3 K to 6.2 K (-1.60 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.35 | 838 | 26,271 | 6,254 | 7.1 K to 6.3 K (-11.82 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.29 | 120 | 3,754 | 7,092 | 7.2 K to 7.1 K (-1.66 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.27 | 10 | 313 | 7,212 | 7.2 K to 7.2 K (-0.14 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.23 | 90 | 2,811 | 7,222 | 7.3 K to 7.2 K (-1.23 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.19 | 200 | 6,238 | 7,312 | 7.5 K to 7.3 K (-2.66 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.14 | 100 | 3,114 | 7,512 | 7.6 K to 7.5 K (-1.31 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.13 | 500 | 15,565 | 7,612 | 8.1 K to 7.6 K (-6.16 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.12 | 90 | 2,801 | 8,112 | 8.2 K to 8.1 K (-1.10 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 31.11 | 20 | 622 | 8,202 | 8.2 K to 8.2 K (-0.24 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 30.99 | 30 | 930 | 8,222 | 8.3 K to 8.2 K (-0.36 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 30.98 | 50 | 1,549 | 8,252 | 8.3 K to 8.3 K (-0.60 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 30.70 | 16 | 491 | 8,302 | 8.3 K to 8.3 K (-0.19 %) |
| May 20 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 3,254 | 33,842 | 8,318 | 5.1 K to 8.3 K (+64.26 %) |
| Apr 11 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 3,750 | 39,000 | 82,788 | |
| Apr 11 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 0.00 | 8,113 | 0 | 17,848 | |
| Apr 11 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Payment of Exercise | F | 34.57 | 3,049 | 105,404 | 5,064 | 8.1 K to 5.1 K (-37.58 %) |
| Apr 11 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 0.00 | 8,113 | 0 | 8,113 | 0 to 8.1 K |
| Apr 11 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 34.50 | 2,100 | 72,450 | 0 | 2.1 K to 0 (-100.00 %) |
| Apr 11 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 34.38 | 100 | 3,438 | 2,100 | 2.2 K to 2.1 K (-4.55 %) |
| Apr 11 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 34.38 | 200 | 6,875 | 2,200 | 2.4 K to 2.2 K (-8.33 %) |
| Apr 11 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 34.35 | 200 | 6,870 | 2,400 | 2.6 K to 2.4 K (-7.69 %) |
| Apr 11 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 34.33 | 100 | 3,433 | 2,600 | 2.7 K to 2.6 K (-3.70 %) |
| Apr 11 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 34.32 | 100 | 3,432 | 2,700 | 2.8 K to 2.7 K (-3.57 %) |
| Apr 11 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 34.31 | 300 | 10,293 | 2,800 | 3.1 K to 2.8 K (-9.68 %) |
| Apr 11 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 34.30 | 300 | 10,290 | 3,100 | 3.4 K to 3.1 K (-8.82 %) |
| Apr 11 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 34.29 | 100 | 3,429 | 3,400 | 3.5 K to 3.4 K (-2.86 %) |
| Apr 11 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 34.25 | 200 | 6,850 | 3,500 | 3.7 K to 3.5 K (-5.41 %) |
| Apr 11 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 33.86 | 50 | 1,693 | 3,700 | 3.8 K to 3.7 K (-1.33 %) |
| Apr 11 2013 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 3,750 | 39,000 | 3,750 | 0 to 3.8 K |
Page: 1